title: [Survey of diagnosis and treatment of acute pulmonary embolism in 21 hospitals in China].
abstract: OBJECTIVE
  To understand the diagnostic and therapeutic status of acute pulmonary embolism in China.
  
  
  METHODS
  Clinical data of 297 patients with acute pulmonary embolism were registered in 21 hospitals in China that participated in the "multicenter clinical trial on the efficacy of thrombolytic therapy with urokinase and/ or anticoagulation with low molecular weight heparin (Fluxum) in patients with acute pulmonary embolism" from August 1997 to July 1999.
  
  
  RESULTS
  297 patients with acute pulmonary embolism were diagnosed and treated in the 21 hospitals during 2 years. The total effective rate of thrombolytic therapy was 80.8% (231/286), and the mortality rate was 9.8% (28/286).
  
  
  CONCLUSIONS
  Acute pulmonary embolism is a common disease. In order to decrease the rate of misdiagnosis and missed diagnosis it is necessaryto raise the consciousness of diagnosis. Thrombolytic therapy is an effective first-aid meaure.
authors.affiliation: Fuwai Hospital, Beijing 100037, China.
authors.forename: J
authors.initials: J
authors.lastname: He
authors.forename: X
authors.initials: X
authors.lastname: Cheng
authors.forename: M
authors.initials: M
authors.lastname: Gao
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002681:China / Q000453:epidemiology; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D015912:Thrombolytic Therapy; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
chemical_list: D006495:Heparin, Low-Molecular-Weight; D014568:Urokinase-Type Plasminogen Activator